Is CLPT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CLPT. It does not provide personalized investment advice.

CLPT (ClearPoint Neuro, Inc. Common Stock) Stock Analysis - Financials

ClearPoint Neuro, Inc. Common Stock (CLPT) is a publicly traded Healthcare sector company. As of July 22, 2026, CLPT trades at $15.41 with a market cap of $451.34M and a P/E ratio of -21.78. CLPT moved +2.33% today. Year to date, CLPT is +12.65%; over the trailing twelve months it is +40.35%. Its 52-week range spans $8.27 to $30.10. Analyst consensus is strong buy with an average price target of $28.33. Rallies surfaces CLPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CLPT's key financials?

CLPT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLPT recently traded at $15.41. Market cap is $451.34M. P/E ratio is -21.78. Revenue is $31.39M.

CLPT Key Metrics

Key financial metrics for CLPT
Metric	Value
Price	$15.41
Market Cap	$451.34M
P/E Ratio	-21.78
EPS	$-0.70
Dividend Yield	0.00%
52-Week High	$30.10
52-Week Low	$8.27
Volume	487.43K
Avg Volume	0
Revenue (TTM)	$31.39M
Net Income	$-18.91M
Gross Margin	60.92%

CLPT Analyst Consensus

3 analysts cover CLPT: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $28.33.

Common questions about CLPT

What are CLPT's key financials?: CLPT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLPT recently traded at $15.41. Market cap is $451.34M. P/E ratio is -21.78. Revenue is $31.39M.
Is CLPT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CLPT. It does not provide personalized investment advice.